Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA) : The Turkish hematology research and education group (ThREG)-TMA02 study
Copyright © 2021 Elsevier Ltd. All rights reserved..
Thrombotic microangiopathy(TMA) is a pathological diagnosis characterized by abnormalities of small vessels leading to microvascular thrombosis of arterioles and capillaries. The current prospective, non-interventional, multicenter (n:18) study aimed to define distribution of different TMA forms in adult Turkish patients who were referred for therapeutic plasma exchange (TPE) for a presumptive diagnosis of TMA. Patients with serum ADAMTS13 activity <5% were diagnosed as acquired thrombotic thrombocytopenic purpura (aTTP). Patients presenting with ADAMTS13 activity 6-10 % / normal renal function and patients with ADAMTS13 activity >10 %, normal renal function and no secondary TMA were treated as unclassified TMA. The study included a total of 97 patients (female: 60; male: 30) with a median age of 48 (18-74). Detailed evaluation at 1 month after hospital admission revealed aTTP, secondary TMA, infection/complement-associated hemolytic uremic syndrome and unclassified TMA in 32 (33 %), 33 (34 %), 26 (27 %) and 6 (6%) patients respectively. As subclassification of various TMAs will dictate specific therapy, proper diagnosis in a timely manner is of utmost clinical significance.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - year:2021 |
---|---|
Enthalten in: |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis - (2021) vom: 16. Nov., Seite 103312 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Akpınar, Seval [VerfasserIn] |
---|
Links: |
---|
Themen: |
Hematopoietic cell transplantation |
---|
Anmerkungen: |
Date Revised 20.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.transci.2021.103312 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333366042 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM333366042 | ||
003 | DE-627 | ||
005 | 20240220231939.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.transci.2021.103312 |2 doi | |
028 | 5 | 2 | |a pubmed24n1300.xml |
035 | |a (DE-627)NLM333366042 | ||
035 | |a (NLM)34799244 | ||
035 | |a (PII)S1473-0502(21)00312-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Akpınar, Seval |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA) |b The Turkish hematology research and education group (ThREG)-TMA02 study |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
520 | |a Thrombotic microangiopathy(TMA) is a pathological diagnosis characterized by abnormalities of small vessels leading to microvascular thrombosis of arterioles and capillaries. The current prospective, non-interventional, multicenter (n:18) study aimed to define distribution of different TMA forms in adult Turkish patients who were referred for therapeutic plasma exchange (TPE) for a presumptive diagnosis of TMA. Patients with serum ADAMTS13 activity <5% were diagnosed as acquired thrombotic thrombocytopenic purpura (aTTP). Patients presenting with ADAMTS13 activity 6-10 % / normal renal function and patients with ADAMTS13 activity >10 %, normal renal function and no secondary TMA were treated as unclassified TMA. The study included a total of 97 patients (female: 60; male: 30) with a median age of 48 (18-74). Detailed evaluation at 1 month after hospital admission revealed aTTP, secondary TMA, infection/complement-associated hemolytic uremic syndrome and unclassified TMA in 32 (33 %), 33 (34 %), 26 (27 %) and 6 (6%) patients respectively. As subclassification of various TMAs will dictate specific therapy, proper diagnosis in a timely manner is of utmost clinical significance | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Hematopoietic cell transplantation | |
650 | 4 | |a Hemolytic uremic syndrome | |
650 | 4 | |a Thrombotic microangiopathy | |
650 | 4 | |a Thrombotic thrombocytopenic purpura | |
700 | 1 | |a Tekgunduz, Emre |e verfasserin |4 aut | |
700 | 1 | |a Erkurt, Mehmet Ali |e verfasserin |4 aut | |
700 | 1 | |a Esen, Ramazan |e verfasserin |4 aut | |
700 | 1 | |a Yılmaz, Mehmet |e verfasserin |4 aut | |
700 | 1 | |a Karakus, Volkan |e verfasserin |4 aut | |
700 | 1 | |a Vural, Filiz |e verfasserin |4 aut | |
700 | 1 | |a Gediz, Fusun |e verfasserin |4 aut | |
700 | 1 | |a Aydogdu, Ismet |e verfasserin |4 aut | |
700 | 1 | |a Kaynar, Leylagul |e verfasserin |4 aut | |
700 | 1 | |a Korkmaz, Serdal |e verfasserin |4 aut | |
700 | 1 | |a Goker, Hakan |e verfasserin |4 aut | |
700 | 1 | |a Kelkitli, Engin |e verfasserin |4 aut | |
700 | 1 | |a Ayyıldız, Orhan |e verfasserin |4 aut | |
700 | 1 | |a Demirkan, Fatih |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis |d 2001 |g (2021) vom: 16. Nov., Seite 103312 |w (DE-627)NLM114008043 |x 1473-0502 |7 nnns |
773 | 1 | 8 | |g year:2021 |g day:16 |g month:11 |g pages:103312 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.transci.2021.103312 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2021 |b 16 |c 11 |h 103312 |